These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38926672)

  • 1. The predictive value of cardiovascular outcomes and mortality assessed by the C-reactive protein to albumin ratio in the UK Biobank.
    Wändell P; Carlsson AC; Larsson AO; Ärnlöv J; Ruge T; Rydell A
    BMC Cardiovasc Disord; 2024 Jun; 24(1):326. PubMed ID: 38926672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-reactive protein Albumin ratio was not consistently associated with cardiovascular and all-cause mortality in two community-based cohorts of 70-year-olds.
    Wändell P; Carlsson AC; Larsson A; Ärnlöv J; Feldreich T; Ruge T
    Scand J Clin Lab Invest; 2023 Nov; 83(7):439-443. PubMed ID: 37702518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of blood pressure and C-reactive protein with the risk of mortality from coronary heart and cardiovascular diseases.
    Kurl S; Jae SY; Voutilainen A; Laukkanen JA
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2051-2057. PubMed ID: 34090772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between C-reactive protein/albumin ratio and all-cause mortality in patients with stroke: Evidence from NHANES cohort study.
    Yuan J; Cheng Y; Han X; Zhu N; Ma W; Li J; Jiang S; Zhao J; Liu F
    Nutr Metab Cardiovasc Dis; 2024 Oct; 34(10):2305-2314. PubMed ID: 39004593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating biomarkers for long-term cardiovascular risk stratification in apparently healthy individuals from the MONICA 10 cohort.
    Frary CE; Blicher MK; Olesen TB; Stidsen JV; Greve SV; Vishram-Nielsen JK; Rasmussen SL; Olsen MH; Pareek M
    Eur J Prev Cardiol; 2020 Apr; 27(6):570-578. PubMed ID: 31718257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Total and Differential Leukocyte Counts With Cardiovascular Disease and Mortality in the UK Biobank.
    Welsh C; Welsh P; Mark PB; Celis-Morales CA; Lewsey J; Gray SR; Lyall DM; Iliodromiti S; Gill JMR; Pell J; Jhund PS; Sattar N
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1415-1423. PubMed ID: 29699973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
    Burger PM; Pradhan AD; Dorresteijn JAN; Koudstaal S; Teraa M; de Borst GJ; van der Meer MG; Mosterd A; Ridker PM; Visseren FLJ;
    Am J Cardiol; 2023 Jun; 197():13-23. PubMed ID: 37218417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes.
    Sharif S; Van der Graaf Y; Cramer MJ; Kapelle LJ; de Borst GJ; Visseren FLJ; Westerink J;
    Cardiovasc Diabetol; 2021 Nov; 20(1):220. PubMed ID: 34753497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waist-to-height ratio and body fat percentage as risk factors for ischemic cardiovascular disease: a prospective cohort study from UK Biobank.
    Feng Q; Bešević J; Conroy M; Omiyale W; Woodward M; Lacey B; Allen N
    Am J Clin Nutr; 2024 Jun; 119(6):1386-1396. PubMed ID: 38839194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of high uric acid and high C-reactive protein increased the risk of cardiovascular disease: A 15-year prospective cohort study.
    Li N; Wu S; Shu R; Song H; Wang J; Chen S; Yang W; Wang G; Yang J; Yang X; Tse G; Zhang N; Cui L; Liu T
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1508-1517. PubMed ID: 38503620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum calcium, vitamin D, and C-reactive protein with all-cause and cause-specific mortality in an osteoarthritis population in the UK: a prospective cohort study.
    Fu K; Cai Q; Jin X; Chen L; Oo WM; Duong V; Li G; Zhu Z; Ding C; Zhang C; Gao Y; Hunter DJ
    BMC Public Health; 2024 Aug; 24(1):2286. PubMed ID: 39175018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between C-reactive protein and traditional risk factors in predicting mortality of older adults.
    Rudolf H; Wall N; Klaassen-Mielke R; Thiem U; Diehm C; Trampisch HJ; Krause D
    Vasa; 2017 Mar; 46(2):127-133. PubMed ID: 28102774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
    Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation biomarkers and mortality prediction in patients with type 2 diabetes (ZODIAC-27).
    Landman GW; Kleefstra N; Groenier KH; Bakker SJ; Groeneveld GH; Bilo HJ; van Hateren KJ
    Atherosclerosis; 2016 Jul; 250():46-51. PubMed ID: 27179179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
    Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
    J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-specific physical activity measured by accelerometer and the risk of mortality among individuals with cardiometabolic diseases: A prospective study from the UK Biobank.
    Liu Y; Yang Y; Wu H; Yang H; Chen L; Sun F; Xia Y
    Int J Nurs Stud; 2024 Aug; 156():104786. PubMed ID: 38788260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.
    Cao JJ; Arnold AM; Manolio TA; Polak JF; Psaty BM; Hirsch CH; Kuller LH; Cushman M
    Circulation; 2007 Jul; 116(1):32-8. PubMed ID: 17576871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic risk stratification using C-reactive protein, albumin, and associated inflammatory biomarkers in patients with advanced cancer in palliative care.
    Silva GAD; Oliveira LC; Wiegert EVM; Calixto-Lima L; Cunha GDC; Peres WAF
    Curr Probl Cancer; 2024 Aug; 51():101115. PubMed ID: 38943779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.